InvestorsHub Logo
Followers 40
Posts 7682
Boards Moderated 1
Alias Born 01/04/2006

Re: None

Tuesday, 01/24/2012 5:41:10 PM

Tuesday, January 24, 2012 5:41:10 PM

Post# of 506
Sinovac Biotech receives Nasdaq deficiency letter regarding audit committee requirement (SVA) 2.22 +0.00 : Co announced that it received a letter dated January 18, 2012 from The Nasdaq Stock Market. Based on the departure of Chup Hung Mok from the Company's Board of Directors effective January 4, 2012, Nasdaq has determined that the Company no longer complies with Nasdaq's requirement that its audit committee consists of at least three independent directors, as set forth in Listing Rule 5605.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SVA News